Glioblastoma
📧 Sign up to get email alerts when something new happens for Glioblastoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-10-26Clinical Trial Update: Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme [Phase 2]
A prospective Phase 2 trial of cabazitaxel in temozolomide-refractory glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2017-10-25Clinical Trial Update: Using Genomic Analysis to Guide Individual Treatment in Glioblastoma
A completed Rockefeller University clinical trial investigates using tumor genomic analysis to guide individualized treatment for glioblasto…
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors
Update on a University of Miami trial evaluating metabolic tumor volumes during radiation therapy for glioblastoma, with the study status sh…
-
CLINICAL_TRIALS trial_result · 2017-10-24Clinical Trial Update: Virus DNX2401 and Temozolomide in Recurrent Glioblastoma [Phase 1]
Clinical trial update reporting on a Phase 1 study of DNX-2401 in combination with temozolomide for recurrent glioblastoma.
-
CLINICAL_TRIALS trial_result · 2017-10-17Clinical Trial Update: Concomitant Association of Ultrafractionated Brain Irradiation - Temozolomide in Inoperable Primary Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating concomitant ultrfractionated brain irradiation with temozolomide for inoperable primary glioblastoma multiforme h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-10-13Clinical Trial Update: MET-PET for Newly Diagnosed Glioblastoma [EARLY_Phase 1]
A MET-PET imaging study for newly diagnosed Glioblastoma has completed its EARLY Phase 1 trial.
-
CLINICAL_TRIALS trial_result · 2017-10-09Clinical Trial Update: Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma [Phase 1]
Phase 1 trial assessing adoptive immunotherapy with genetically modified T-lymphocytes for recurrent or refractory high-grade malignant glio…
-
CLINICAL_TRIALS trial_result · 2017-08-18Clinical Trial Update: Efficacy and Safety of Atorvastatin in Combination With Radiotherapy and Temozolomide in Glioblastoma [Phase 2]
Phase 2 study evaluating the efficacy and safety of adding atorvastatin to radiotherapy and temozolomide in glioblastoma; trial completed.
-
CLINICAL_TRIALS trial_result · 2017-08-16Clinical Trial Update: GDC-0449 in Treating Patients With Recurrent Glioblastoma Multiforme That Can Be Removed by Surgery [Phase 2]
Phase 2 trial of vismodegib (GDC-0449) in patients with recurrent glioblastoma multiforme that could be surgically removed; the study is com…
-
CLINICAL_TRIALS trial_result · 2017-08-14Clinical Trial Update: Gliadel Wafer and Fluorescence-Guided Surgery With 5-ALA Followed by Radiation Therapy And Temozolomide in Treating Patients With Primary Glioblastoma [Phase 2]
Phase 2 trial evaluating Gliadel Wafer with fluorescence-guided surgery using 5-ALA followed by radiation therapy and temozolomide in patien…
-
CLINICAL_TRIALS trial_result · 2017-08-08Clinical Trial Update: Dovitinib in Treating Patients With Recurrent or Progressive Glioblastoma [Phase 2]
Phase 2 trial update for dovitinib in adults with recurrent or progressive glioblastoma. The study is completed, with results posted in 2017…
-
CLINICAL_TRIALS trial_result · 2017-08-07Clinical Trial Update: p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors [Phase 1]
This Phase 1 trial tests the safety of the p28 peptide in younger patients with recurrent or progressive central nervous system tumors and t…
-
CLINICAL_TRIALS trial_result · 2017-08-01Clinical Trial Update: Glioblastoma Platelet Activation Study
This clinical trial update reports that the study on glioblastoma evaluating platelet activation and circulating platelet-monocyte conjugate…
-
CLINICAL_TRIALS trial_result · 2017-07-27Clinical Trial Update: Erlotinib Compared With Temozolomide or Carmustine in Treating Patients With Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 trial comparing erlotinib with temozolomide or carmustine in patients with recurrent glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2017-07-14Clinical Trial Update: Safety and Efficacy of Trans Sodium Crocetinate (TSC) With Radiation and Temozolomide in Newly Diagnosed Glioblastoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and efficacy of Trans Sodium Crocetinate in combination with radiation and temozolomide for newly diagnose…
-
CLINICAL_TRIALS trial_result · 2017-07-13Clinical Trial Update: Erlotinib in Treating Patients With Recurrent Malignant Glioma or Recurrent or Progressive Meningioma [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating erlotinib in adults with recurrent malignant glioma or recurrent/progressive meningioma; the study is co…
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Bevacizumab (Avastin) Into the Tumor Resection Cavity in Subjects With Glioblastoma Multiforme at First Recurrence [Phase 1]
Phase 1 study evaluating bevacizumab delivered into the tumor resection cavity for glioblastoma at first recurrence has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-07-11Clinical Trial Update: Temozolomide, Thalidomide, and Celecoxib Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating the combination of temozolomide, thalidomide, and celecoxib after radiation therapy in newly diagnosed glioblastoma…
-
CLINICAL_TRIALS trial_result · 2017-07-02Clinical Trial Update: Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma [Phase 1, Phase 2]
Clinical trial update reporting results from a Phase 1/2 study of veliparib plus temozolomide in patients with recurrent glioblastoma; the t…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Efficacy and Safety Study of Lomustine/Temozolomide Combination Therapy vs. Standard Therapy for Glioblastoma Patients [Phase 3]
This update reports the results of a Phase 3 trial comparing lomustine plus temozolomide versus standard therapy for glioblastoma to evaluat…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Phase II Study of BKM120 for Subjects With Recurrent Glioblastoma [Phase 2]
Phase II trial of BKM120 in recurrent glioblastoma has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: Cilengitide in Treating Patients Who Are Undergoing Surgery for Recurrent or Progressive Glioblastoma Multiforme [Phase 2]
Phase 2 trial of cilengitide in adults undergoing surgery for recurrent or progressive glioblastoma multiforme was terminated and results we…
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma [NA]
A terminated clinical trial evaluating stem cell radiotherapy with temozolomide for newly diagnosed high-grade glioma has posted results.
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Stereotactic Radiosurgery With Nivolumab and Valproate in Patients With Recurrent Glioblastoma [Phase 1]
This Phase 1 study evaluating stereotactic radiosurgery combined with nivolumab and valproate in patients with recurrent glioblastoma has be…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: Amgen 386 for Recurrent Glioblastoma [Phase 1, Phase 2]
Clinical trial update reports completion of Amgen's AMG-386 studies in recurrent glioblastoma (Phase 1/2) with results posted in 2017.